drugset

drugset / Trial / NCT00673725

Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis

NCT00673725 ↗

Phase 4 Completed 49 enrolled Astellas Pharma Europe B.V.

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To assess the efficacy of Locobase REPAIR® when used in children with moderate to severe AD

Timeline

Start: 2008-03
Primary completion: 2008-09
Completion: 2008-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Locobase® REPAIR	Unknown	—	—

Indications